世界中医药
文章摘要
引用本文:赵彩燕 雒晓东 林明欣.帕病1号方治疗强直少动型早期帕金森病28例临床观察[J].世界中医药,2013,8(04):.  
帕病1号方治疗强直少动型早期帕金森病28例临床观察
Clinical Study of PabingⅠFormula for 28 Early Stage Parkinson of Stiffness and Less Dynamic Pattern
投稿时间:2012-12-13  
DOI:
中文关键词:  帕金森病/中医药疗法  帕病1号方  强直少动型
English Keywords:Parkinson/ Chinese medical therapy  PabingⅠFormula  Stiffness and less dynamic pattern
基金项目:广东省科技计划项目(编号:2011971)
作者单位
赵彩燕 雒晓东 林明欣 1 广州中医药大学广州510405 2 广东省中医院广州510000 
摘要点击次数: 1440
全文下载次数: 1153
中文摘要:
      目的:观察帕病1号方对强直少动型早期帕金森病的临床疗效。方法:将58例早期帕金森病患者随机分为2组,治疗组28例予帕病1号方治疗,对照组30例予美多芭治疗,疗程均为2个月。结果:帕病1号方和美多芭均可改善早期帕金森患者的运动症状(P<0.01),且疗效相仿(P>0.05);帕病1号方和美多芭均可改善早期帕金森病患者生活质量(P<0.01),但帕病1号方疗效优于美多芭(P<0.05)。结论:帕病1号方治疗强直少动型早期帕金森病在改善运动症状上疗效与美多芭相仿,在改善生活质量上则优于美多芭。
English Summary:
      To observe the effect of PabingⅠFormula for early stage Parkinson of stiffness and less dynamic pattern.Methods:Fifty eight early stage Parkinson patients were randomed into two groups, the treatment group (N=28) received PabingⅠFormula, the control group (N=30) received madopar. The treatment last for 2 months.Results:Both groups showed improved motor function compared with before treatment (P<0.01), with similar efficacy (P>0.05); patient of both groups had improved quality of life compared with before treatment (P<0.01), and PabingⅠFormula group showed better efficacy (P<0.05).Conclusion:PabingⅠFormula showed motor function improvement similar to the effect of madopar, and was superior to madopar group in improving the quality of life of the patients.
查看全文  查看/发表评论  下载PDF阅读器